Firms
Theme

FNYETF

First Trust Mid Cap Growth AlphaDEX Fund · NASDAQ

News

3 latest

Zacks Investment Research

Should First Trust Mid Cap Growth AlphaDEX ETF (FNY) Be on Your Investing Radar?

First Trust Mid Cap Growth AlphaDEX ETF (FNY) offers exposure to mid-cap growth stocks with $546.86 million in assets. The fund has a 0.73% expense ratio, which is relatively high compared to competitors, and has returned 5.2% year-to-date and 3.41% over the past year.

Zacks Investment Research

Is First Trust Mid Cap Growth AlphaDEX ETF (FNY) a Strong ETF Right Now?

The First Trust Mid Cap Growth AlphaDEX ETF (FNY) is reviewed as a reasonable smart beta option for mid-cap growth investors, with $574.27 million in assets and a 0.73% expense ratio. However, it underperforms cheaper alternatives like Vanguard Morningstar Mid-Cap Growth ETF (VOT) at 0.05% and iShares Russell Mid-Cap Growth ETF (IWP) at 0.23%. FNY has returned 10.52% year-to-date and 8.14% over 12 months with a beta of 1.20, making it a medium-risk choice.

Mentions FNY

Zacks Investment Research

PCE Inflation Less Than Expected: 5 Low P/E Growth ETF Picks

U.S. PCE inflation came in softer than expected in August at 3.4% annually, easing Fed rate hike concerns and pushing markets to expect a December increase rather than October. Q2 GDP was revised upward to 2.2%, showing economic resilience. The article recommends five growth ETFs trading at lower P/E multiples than the S&P 500 as potential beneficiaries of lower interest rate expectations.

Headlines link to the publisher. Not investment advice.

Analysts

All ›

Targets are shown as reported, adjusted only for stock splits, not as predictions. Not investment advice.

Community

7 days

No sentiment yet

Posts 24h
0
Replies 24h
0
Watchers
0

Board · $FNY · 0 threads

Sign in to post on $FNY

No threads yet

Community posts are member opinions. Desk posts are automated weekly counts. Not investment advice.

Cylvex is a financial simulation and community platform designed for educational and informational purposes only. Market data may be delayed. Nothing on this platform constitutes investment advice, financial advice, trading advice, or any other sort of advice. You should not treat any of the platform's content as such. Cylvex does not recommend that any financial instrument should be bought, sold, or held by you. Do conduct your own due diligence and consult your financial advisor before making any investment decisions. By using Cylvex, you acknowledge that you are using the platform at your own risk.

Terms · Privacy · Disclaimer · Methodology · Logos provided by Logo.dev